0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Genetic Testing Market by Type (Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others), Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), Application (Cancer diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
Published Date: September 2020
|
Report Code: ALLI-Auto-0I340
Home | Market Reports | Science| Biological Sciences
Genetic Testing Market by Type Predictive Presymptomatic Testing Carrier Testing Prenatal Newborn Testing Diagnostic Testing Pharmacogenomic Testing and Others Technology Cytogenetic Testing Biochemical Testing and Molecular Testing Application Cancer diagnosis Genetic Disease Diagnosis Cardiovascular Disease Diagnosis and Others Global Opportunity Analysis and Industry Forecast 2020 2027

Genetic Testing Market by Type (Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others), Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), Application (Cancer diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027

Code: ALLI-Auto-0I340
Report
September 2020
247 Pages
Allied Market Research
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Genetic Testing Market 

The genetic testing market accounted for USD 12,682 Million in 2019, and is expected to reach USD 21,260 Million by 2027, registering a CAGR of 10.1% from 2020 to 2027.  Key drivers of the genetic testing market include increasing cases of genetic disorders, cancers and global acceptance of personalized medicines.
 
Genetic Testing Market
 
In addition to it, rapid technological developments in gene testing will spur the growth of the genetic testing market during the forecast period. Further, strict regulatory compliance and standardization issues will restrict the market. However, huge potential in emerging economies will create ample opportunities for growth during the forecast period.
 
< Genetic testing market size

Trends Influencing the Global Genetic Testing Market 

Increasing cases of genetic disorders, cancers, and global acceptance of personalized medicines

Genetic disorders are a leading cause of death, disability, and human tragedy. The increasing number of genetic disorders such as down syndrome, sickle cell disease, and growing cancer cases are necessitating the need for genetic testing. On the other hand, personalized medicine is gaining global acceptance as treatments are tailored to every individual as much as possible. Genomic testing forms an essential part of it. Thus the increasing number of genetic disorders, cancers, and growing global acceptance of personalized medicine are expected to drive the growth of the genetic testing market during the forecast period.

Rapid technological advancements in gene testing

Genetic technology is advancing rapidly. Genome sequencing has become simpler and cheaper. This opens up new possibilities such as genetic testing or genome editing to a wider group of people and organizations. Uses include DNA sequencing for treating rare diseases, commercial purposes, and for designing treatments that are in sync with individual genetic structures. Thus huge potential offered by rapid technological advancements in gene testing will create lucrative opportunities for growth in the genetic testing market in the coming years.

Strict regulatory compliance, standardization issues, and huge potential in emerging economies

Genetic testing has strict regulatory compliance in various countries. This is due to ethical concerns and the emergence of online Direct To Consumer testing services which require a multitude of medical and regulatory approvals. This makes it challenging and expensive for companies to gain product approval. Also, no set standards are currently present to deal with DNA analysis. However, emerging economies provide huge potential as the public health burden of genetic disorders is very high rather than in the industrialized world. Moreover, the healthcare infrastructure is growing rapidly in the region due to increasing investments. Thus strict regulatory requirements and standardization issues will hamper growth but huge potential in developing nations will create ample opportunities for the growth of the genetic testing market in the future.

Genetic Testing Market Market Share Analysis

Based on type, the prenatal and newborn segment is expected to provide lucrative opportunities for growth in the genetic testing market share and held about one-third of the market in 2019. This is due to increasing awareness and growing mortality rates. The pharmacogenomic testing segment will grow the fastest during the forecast period due to the increasing acceptance of personalized medicine.

Based on technology, the molecular testing segment is expected to provide lucrative opportunities for growth in the genetic testing market share as this is the widely used technology for gene testing. On the other hand, biochemical testing will grow the fastest during the forecast period.

gentic testing market technology

Based on application, the genetic disease diagnosis segment held one-third market share in 2019 and is expected to provide lucrative opportunities for growth in the genetic testing market share during the forecast period.

Based on region, North America dominated the market in 2019 and is expected to provide lucrative opportunities for growth in the genetic testing market share due to the presence of major market players. However, the Asia- Pacific segment will grow at the fastest CAGR of 12.5% during the forecast period due to cheaper medical costs, a surge in healthcare spending, and growing awareness.

Genetic Testing Market Segmentation

  • By Type

    • Predictive & Presymptomatic Testing
    • Carrier Testing
    • Prenatal & Newborn Testing
    • Diagnostic Testing
    • Pharmacogenomic Testing
    • Others
  • By Technology

    • Cytogenetic Testing
    • Biochemical Testing
    • Molecular Testing
  • By Application

    • Cancer diagnosis
    • Genetic Disease Diagnosis
    • Cardiovascular Disease Diagnosis
    • Others
  • By Region

    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA

Key Players

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.)
  • Myriad Genetics, Inc. (Myriad RBM, Inc.)
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche Ltd.
  • Eurofins Scientific
  • Illumina, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific, Inc.
  • CSL Ltd.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • PerkinElmer, Inc.
  • Natera
  • Sonic Healthcare

Scope of Genetic Testing Market Report Coverage

Report Metric

Details

Report Name

Genetic Testing Market

Market size value in 2019

USD 12,682 Million

Revenue forecast in 2027

USD 21,260 Million

Growth Rate

10.1%

Base year considered

2020

Forecast Period

2021-2027

By Type

Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing

By Technology

Cytogenetic Testing, Biochemical Testing, and Molecular Testing

By Application

Cancer diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis

Report Coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

By Type, Application, and Region

Geographic Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report 

1. How big is the Genetic Testing Market?

Ans. The genetic testing market accounted for $ 12,682 million in 2019, and is expected to reach $ 21,260 million by 2027, registering a CAGR of 10.1% from 2020 to 2027. 

2. Who are the key players available in the Genetic Testing Industry?

Ans. Major players operating in the market include Abbott Laboratories, Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Myriad Genetics, Inc. (Myriad RBM, Inc.), Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd., Eurofins Scientific, Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., and CSL Ltd.

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

4. Which Region holds largest market share in the Genetic Testing?

Ans. Asia-Pacific region would exhibit the highest CAGR of 12.5% during 2020-2027.

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in incidences of genetic disorders and cancer
3.5.1.2.Rise in awareness & acceptance of personalized medicines
3.5.1.3.Advancements in genetic testing techniques
3.5.2.Restraints
3.5.2.1.Standardization concerns of genetic testing-based diagnostics
3.5.2.2.Stringent regulatory requirements for product approvals
3.5.3.Opportunities
3.5.3.1.Untapped emerging markets in developing countries
3.6.Patent analysis (2017–2022)
3.6.1.Patent analysis, by year
3.6.2.Patent analysis for year 2019, by country
CHAPTER 4:GENETIC TESTING MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast, by region
4.2.Predictive & presymptomatic testing
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Carrier testing
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Prenatal and newborn testing
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Diagnostic testing
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.6.Pharmacogenomic testing
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
4.7.Others
4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market analysis, by country
CHAPTER 5:GENETIC TESTING MARKET, BY TECHNOLOGY
5.1.Overview
5.1.1.Market size and forecast, by region
5.2.Cytogenetic testing/chromosome analysis
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Biochemical testing
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Molecular testing
5.4.1.Market size and forecast, by region, by type
5.4.1.1.DNA Sequencing
5.4.1.1.1.Market size and forecast, by region
5.4.1.2.Others
5.4.1.2.1.Market size and forecast, by region
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country
CHAPTER 6:GENETIC TESTING MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Cancer diagnosis
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Genetic disease diagnosis
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.4.Cardiovascular disease diagnosis
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
6.5.Others
6.5.1.Market size and forecast
6.5.2.Market analysis, by country
CHAPTER 7:GENETIC TESTING MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by test type
7.2.3.Market size and forecast, by technology
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by country
7.2.5.1.U.S. market size and forecast, by test type
7.2.5.2.U.S. market size and forecast, by technology
7.2.5.3.U.S. market size and forecast, by application
7.2.5.4.Canada market size and forecast, by test type
7.2.5.5.Canada market size and forecast, by technology
7.2.5.6.Canada market size and forecast, by application
7.2.5.7.Mexico market size and forecast, by test type
7.2.5.8.Mexico market size and forecast, by technology
7.2.5.9.Mexico market size and forecast, by application
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by test type
7.3.3.Market size and forecast, by technology
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by country
7.3.5.1.Germany market size and forecast, by test type
7.3.5.2.Germany market size and forecast, by technology
7.3.5.3.Germany market size and forecast, by application
7.3.5.4.France market size and forecast, by test type
7.3.5.5.France market size and forecast, by technology
7.3.5.6.France market size and forecast, by application
7.3.5.7.UK market size and forecast, by test type
7.3.5.8.UK market size and forecast, by technology
7.3.5.9.UK market size and forecast, by application
7.3.5.10.Italy market size and forecast, by test type
7.3.5.11.Italy market size and forecast, by technology
7.3.5.12.Italy market size and forecast, by application
7.3.5.13.Spain market size and forecast, by test type
7.3.5.14.Spain market size and forecast, by technology
7.3.5.15.Spain market size and forecast, by application
7.3.5.16.Rest of Europe market size and forecast, by test type
7.3.5.17.rest of Europe market size and forecast, by technology
7.3.5.18.Rest of Europe market size and forecast, by application
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by test type
7.4.3.Market size and forecast, by technology
7.4.4.Market size and forecast, by application
7.4.5.Market size and forecast, by country
7.4.5.1.Japan market size and forecast, by test type
7.4.5.2.Japan market size and forecast, by technology
7.4.5.3.Japan market size and forecast, by application
7.4.5.4.China market size and forecast, by test type
7.4.5.5.China market size and forecast, by technology
7.4.5.6.China market size and forecast, by application
7.4.5.7.Australia market size and forecast, by test type
7.4.5.8.Australia market size and forecast, by technology
7.4.5.9.Australia market size and forecast, by application
7.4.5.10.India market size and forecast, by test type
7.4.5.11.India market size and forecast, by technology
7.4.5.12.India market size and forecast, by application
7.4.5.13.South Korea market size and forecast, by test type
7.4.5.14.South Korea market size and forecast, by technology
7.4.5.15.South Korea market size and forecast, by application
7.4.5.16.Rest of Asia-Pacific market size and forecast, by test type
7.4.5.17.Rest of Asia-Pacific market size and forecast, by technology
7.4.5.18.Rest of Asia-Pacific market size and forecast, by application
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by test type
7.5.3.Market size and forecast, by technology
7.5.4.Market size and forecast, by application
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil market size and forecast, by test type
7.5.5.2.Brazil market size and forecast, by technology
7.5.5.3.Brazil market size and forecast, by application
7.5.5.4.Saudi Arabia market size and forecast, by test type
7.5.5.5.Saudi Arabia market size and forecast, by technology
7.5.5.6.Saudi Arabia market size and forecast, by application
7.5.5.7.South Africa market size and forecast, by test type
7.5.5.8.South Africa market size and forecast, by technology
7.5.5.9.South Africa market size and forecast, by application
7.5.5.10.Rest of LAMEA market size and forecast, by test type
7.5.5.11.Rest of LAMEA market size and forecast, by technology
7.5.5.12.Rest of LAMEA market size and forecast, by application
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.BIO-RAD LABORATORIES, INC. (RAINDANCE TECHNOLOGIES, INC.)
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.CSL LTD.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.DANAHER CORPORATION (CEPHEID)
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.EUROFINS SCIENTIFIC
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.F. HOFFMANN-LA ROCHE LTD.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segment
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.ILLUMINA, INC.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.MYRIAD GENETICS, INC. (MYRIAD RBM, INC.)
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.QIAGEN N.V. (FORMULATRIX, INC.)
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segment
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.THERMO FISHER SCIENTIFIC, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segment
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and development
LIST OF TABLES

TABLE 01.GLOBAL GENETIC TESTING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 02.GLOBAL GENETIC TESTING MARKET FOR PREDICTIVE & PRESYMPTOMATIC TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 03.GLOBAL GENETIC TESTING MARKET FOR CARRIER TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL GENETIC TESTING MARKET FOR PRENATAL AND NEWBORN TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 05.GLOBAL GENETIC TESTING MARKET FOR DIAGNOSTIC TESTING BY REGION, 2019–2027 ($MILLION)
TABLE 06.GLOBAL GENETIC TESTING MARKET FOR PHARMACOGENOMIC TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL GENETIC TESTING MARKET FOR OTHER TYPES, BY REGION, 2019–2027 ($MILLION)
TABLE 08.GENETIC TESTING MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 09.GENETIC TESTING MARKET FOR CYTOGENETIC TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 10.GENETIC TESTING MARKET FOR BIOCHEMICAL TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 11.GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY TYPE, 2019–2027 ($MILLION)
TABLE 12.GENETIC TESTING MARKET FOR DNA SEQUENCING, BY REGION, 2019–2027 ($MILLION)
TABLE 13.GENETIC TESTING MARKET FOR OTHER MOLECULAR TESTS, BY REGION, 2019–2027 ($MILLION)
TABLE 14.GENETIC TESTING MARKET FOR MOLECULAR TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 15.GENETIC TESTING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 16.GENETIC TESTING MARKET FOR CANCER DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 17.GENETIC TESTING MARKET FOR GENETIC DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 18.GENETIC TESTING MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 19.GENETIC TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2027 ($MILLION)
TABLE 20.GENETIC TESTING MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 21.NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 22.NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 23.NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.NORTH AMERICA GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 25.U.S. GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 26.U.S. GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 27.U.S. GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 28.CANADA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 29.CANADA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 30.CANADA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 31.MEXICO GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 32.MEXICO GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 33.MEXICO GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 34.EUROPE GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 35.EUROPE GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 36.EUROPE GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 37.EUROPE GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 38.GERMANY GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 39.GERMANY GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 40.GERMANY GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 41.FRANCE GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 42.FRANCE GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 43.FRANCE GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 44.UK GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 45.UK GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 46.UK GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 47.ITALY GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 48.ITALY GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 49.ITALY GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 50.SPAIN GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 51.SPAIN GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 52.SPAIN GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 53.REST OF EUROPE GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 54.REST OF EUROPE GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 55.REST OF EUROPE GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 56.ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 57.ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 58.ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 59.ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 60.JAPAN GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 61.JAPAN GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 62.JAPAN GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 63.CHINA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 64.CHINA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 65.CHINA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 66.AUSTRALIA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 67.AUSTRALIA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 68.AUSTRALIA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 69.INDIA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 70.INDIA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 71.INDIA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 72.SOUTH KOREA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 73.SOUTH KOREA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 74.SOUTH KOREA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 75.REST OF ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 76.REST OF ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 77.REST OF ASIA-PACIFIC GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 78.LAMEA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 79.LAMEA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 80.LAMEA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 81.LAMEA GENETIC TESTING MARKET REVENUE, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 82.BRAZIL GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 83.BRAZIL GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 84.BRAZIL GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 85.SAUDI ARABIA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 86.SAUDI ARABIA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 87.SAUDI ARABIA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 88.SOUTH AFRICA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 89.SOUTH AFRICA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 90.SOUTH AFRICA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 91.REST OF LAMEA GENETIC TESTING MARKET REVENUE, BY TEST TYPE, 2019–2027 ($MILLION)
TABLE 92.REST OF LAMEA GENETIC TESTING MARKET REVENUE, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 93.REST OF LAMEA GENETIC TESTING MARKET REVENUE, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 94.ABBOTT: COMPANY SNAPSHOT
TABLE 95.ABBOTT: OERATING SEGMENT
TABLE 96.ABBOTT: PRODUCT PORTFOLIO
TABLE 97.BIO-RAD: COMPANY SNAPSHOT
TABLE 98.BIO-RAD: OPERATING SEGMENTS
TABLE 99.BIO-RAD: PRODUCT PORTFOLIO
TABLE 100.CSL LTD: COMPANY SNAPSHOT
TABLE 101.CSL LTD..: OPERATING SEGMENT
TABLE 102.CSL LTD..: PRODUCT PORTFOLIO
TABLE 103.DANAHER: COMPANY SNAPSHOT
TABLE 104.DANAHER: OPERATING SEGMENTS
TABLE 105.DANAHER: PRODUCT PORTFOLIO
TABLE 106.EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
TABLE 107.EUROFINS SCIENTIFIC.: PRODUCT PORTFOLIO
TABLE 108.ROCHE: COMPANY SNAPSHOT
TABLE 109.ROCHE: OPERATING SEGMENT
TABLE 110.ROCHE: PRODUCT PORTFOLIO
TABLE 111.ILLUMINA: COMPANY SNAPSHOT
TABLE 112.ILLUMINA: OPERATING SEGMENTS
TABLE 113.ILLUMINA: PRODUCT PORTFOLIO
TABLE 114.MYRIAD: COMPANY SNAPSHOT
TABLE 115.MYRIAD: OPERATING SEGMENTS
TABLE 116.MYRIAD: PRODUCT PORTFOLIO
TABLE 117.QIAGEN: COMPANY SNAPSHOT
TABLE 118.QIAGEN: PRODUCT SEGMENT
TABLE 119.QIAGEN: PRODUCT PORTFOLIO
TABLE 120.THERMO FISHER SCIENTIFIC.: COMPANY SNAPSHOT
TABLE 121.THERMO FISHER SCIENTIFIC: PRODUCT SEGMENT
TABLE 122.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01.SEGMENTATION OF GENETIC TESTING MARKET
FIGURE 02.TOP INVESTMENT POCKETS, 2019
FIGURE 03.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.LOW THREAT OF SUBSTITUTION
FIGURE 06.HIGH THREAT OF NEW ENTRANT
FIGURE 07.HIGH COMPETITIVE RIVALRY
FIGURE 08.GLOBAL GENETIC TESTING TOP PLAYER POSITIONING, 2019
FIGURE 09.GLOBAL GENETIC TESTING MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10.PATENTS REGISTERED/APPROVED IN THE WORLD, 2017-2022
FIGURE 11.PATENTS ANALYSIS BY YEAR, 2017 THROUGH 2022
FIGURE 12.YEAR 2019 PATENT ANALYSIS, BY COUNTRY
FIGURE 13.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY PREDICTIVE & PRESYMPTOMATIC TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY CARRIER TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY PRENATAL AND NEWBORN TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY DIAGNOSTIC TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY PHARMACOGENOMIC TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY OTHER TYPES, BY REGION, 2019–2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY CYTOGENETIC TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY BIOCHEMICAL TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY MOLECULAR TESTING, BY REGION, 2019–2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY CANCER DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY GENETIC DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY CARDIOVASCULAR DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OF GENETIC TESTING MARKET, BY OTHER, BY REGION, 2019–2027 ($MILLION)
FIGURE 26.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 27.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 28.ABBOTT: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 29.BIO-RAD: NET SALES, 2017–2019 ($MILLION)
FIGURE 30.BIO-RAD: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 31.BIO-RAD: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 32.CSL LTD.: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.CSL LTD.: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 34.CSL LTD.: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 35.DANAHER CORPORATION: NET SALES, 2017–2019 ($MILLION)
FIGURE 36.DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 37.DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 38.EUROFINS SCIENTIFIC.: REVENUE, 2017–2019 ($MILLION)
FIGURE 39.EUROFINS SCIENTIFIC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 40.ROCHE: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.ILLUMINA: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.ILLUMINA: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.ILLUMINA: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 46.MYRIAD: NET SALES, 2018–2020 ($MILLION)
FIGURE 47.MYRIAD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 48.QIAGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.QIAGEN: REVENUE SHARE, BY PRODUCT, 2019 (%)
FIGURE 50.QIAGEN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.THERMO FISHER SCIENTIFIC. REVENUE SHARE, BY REGION, 2019 (%
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5769

This license allows only one user to access the PDF.
Electronic (PDF)

$6450

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8995

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Electronic (PDF)

$3840

This license just provides quantitative data in a excel sheet
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS